Relay Therapeutics RLAY
NASDAQ RLAY
$18.18 -0.16 (-0.87%)
At close: Oct 23, 2026 · 4:00 PM EDT

Relay Therapeutics (RLAY) Cash & Current Investments (2019 - 2026)

Updated

Relay Therapeutics' Cash & Current Investments came in at $121.19 million for Q2 2026, up 6.4% from $113.94 million a year earlier but down 40.8% from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Relay Therapeutics' Cash & Current Investments was $84.02 million, down 32.4% from FY2024.

  • Cash & Current Investments has declined in each of the last five years, with a five-year compound annual growth rate of -28.4% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $124.29 million in FY2024 (-13.5%), $143.74 million in FY2023 (-5.3%), $151.79 million in FY2022 (-45.8%) and $280.12 million in FY2021 (-37.4%).
  • The five-year range for quarterly Cash & Current Investments is $84.02 million (Q4 2025) to $354.64 million (Q3 2022).
  • Year-over-year, Cash & Current Investments increased in three of the last eight quarters, with an average decline of 1.7%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q1 2026 (growth of 118.7%), and the weakest in Q3 2021 (a decline of 59.1%).
  • Business Quant data shows RLAY's Cash & Current Investments at $204.59 million (Q1 2026), $84.02 million (Q4 2025) and $91.56 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Relay Therapeutics 3.68 Bn 3.18 Bn - 121.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121.19 Mn
Mar 31, 2026 204.59 Mn
Dec 31, 2025 84.02 Mn
Sep 30, 2025 91.56 Mn
Jun 30, 2025 113.94 Mn
Mar 31, 2025 93.54 Mn
Dec 31, 2024 124.29 Mn
Sep 30, 2024 152.36 Mn
Jun 30, 2024 134.13 Mn
Mar 31, 2024 152.87 Mn
Dec 31, 2023 143.74 Mn
Sep 30, 2023 151.33 Mn
Jun 30, 2023 145.90 Mn
Mar 31, 2023 161.28 Mn
Dec 31, 2022 151.79 Mn
Sep 30, 2022 354.64 Mn
Jun 30, 2022 107.74 Mn
Mar 31, 2022 119.45 Mn
Dec 31, 2021 280.12 Mn
Sep 30, 2021 228.56 Mn
API Access

Relay Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RLAY&period=max&api_key=YOUR_API_KEY